U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C14H21ClN2O2.C4H4O4
Molecular Weight 400.854
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 2
Charge 0

SHOW SMILES / InChI
Structure of CLOVOXAMINE FUMARATE

SMILES

OC(=O)\C=C\C(O)=O.COCCCC\C(=N/OCCN)C1=CC=C(Cl)C=C1

InChI

InChIKey=HOFGGHPYWKSXTN-QCHLHFLZSA-N
InChI=1S/C14H21ClN2O2.C4H4O4/c1-18-10-3-2-4-14(17-19-11-9-16)12-5-7-13(15)8-6-12;5-3(6)1-2-4(7)8/h5-8H,2-4,9-11,16H2,1H3;1-2H,(H,5,6)(H,7,8)/b17-14+;2-1+

HIDE SMILES / InChI
Clovoxamine is an antidepressant and anxiolytic drug, acting as a serotonin and norepinephrine reuptake inhibitor. The drug was investigated in the double-blind clinical trials for the treatment of anxiety neurosis, where it was compared with diazepam, and found to have comparable efficacy but higher drop out rate.

Approval Year

Patents
Name Type Language
CLOVOXAMINE FUMARATE
Common Name English
1-PENTANONE, 1-(4-CHLOROPHENYL)-5-METHOXY-, O-(2-AMINOETHYL)OXIME, (1E)-, (2E)-2-BUTENEDIOATE (1:1)
Common Name English
Code System Code Type Description
CAS
54739-21-8
Created by admin on Fri Dec 15 15:36:53 GMT 2023 , Edited by admin on Fri Dec 15 15:36:53 GMT 2023
PRIMARY
PUBCHEM
9576737
Created by admin on Fri Dec 15 15:36:53 GMT 2023 , Edited by admin on Fri Dec 15 15:36:53 GMT 2023
PRIMARY
EPA CompTox
DTXSID40866440
Created by admin on Fri Dec 15 15:36:53 GMT 2023 , Edited by admin on Fri Dec 15 15:36:53 GMT 2023
PRIMARY
FDA UNII
21VG81S0IX
Created by admin on Fri Dec 15 15:36:53 GMT 2023 , Edited by admin on Fri Dec 15 15:36:53 GMT 2023
PRIMARY